{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:vm:venous-malformations",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-08T21:18:00.000Z",
    "updated": "2026-01-08T21:18:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent"
    ],
    "confidence": 0.95,
    "status": "peer-reviewed",
    "review_status": "pending_review",
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/vascular-malformations",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "topic_id": "VM-007"
  },
  "content": {
    "title": "Venous Malformations",
    "definition": {
      "primary": "Slow-flow vascular malformations composed of abnormal, ectatic venous channels lined by flat endothelium, present at birth but often becoming clinically apparent later in life, characterized by blue discoloration, compressibility, and phleboliths.",
      "key_concepts": [
        "Most common type of vascular malformation (2:1 over AVMs)",
        "Low-flow lesions (distinguish from high-flow AVMs)",
        "Present at birth, grow proportionally with child, may expand with puberty/pregnancy",
        "ISSVA classification: simple vascular malformations, slow-flow type"
      ]
    },
    "classification": {
      "issva_system": {
        "category": "Vascular malformations - slow-flow",
        "subtype": "Venous malformation (VM)",
        "simple_vs_combined": [
          "Simple VM: Venous only",
          "Combined: VM with other malformation types (e.g., capillary-venous)"
        ]
      },
      "anatomic": {
        "superficial": "Subcutaneous, visible blue discoloration",
        "deep": "Intramuscular, intraarticular, visceral",
        "diffuse": "Involving multiple tissue planes",
        "localized": "Discrete, well-defined lesion"
      },
      "genetic_subtypes": [
        {
          "type": "Sporadic VM",
          "genetics": "Somatic TIE2/TEK mutations (most common)",
          "characteristics": "Usually unifocal"
        },
        {
          "type": "Multifocal VM/Blue rubber bleb nevus syndrome",
          "genetics": "TEK mutations (can be germline)",
          "characteristics": "Multiple cutaneous and GI lesions"
        },
        {
          "type": "Glomuvenous malformation (GVM)",
          "genetics": "GLMN (glomulin) mutations",
          "characteristics": "Painful, less compressible, cobblestone appearance"
        }
      ]
    },
    "pathophysiology": {
      "molecular": {
        "primary_pathway": "TIE2/PI3K/AKT signaling dysregulation",
        "effect": "Abnormal endothelial cell function, impaired smooth muscle recruitment",
        "result": "Dilated, irregular venous channels with deficient smooth muscle wall"
      },
      "flow_characteristics": {
        "type": "Low-flow/slow-flow",
        "consequences": [
          "Blood stasis",
          "Localized intravascular coagulopathy",
          "Phlebolith formation",
          "Thrombosis episodes"
        ]
      }
    },
    "clinical_features": {
      "appearance": {
        "color": "Blue or purple discoloration",
        "texture": "Soft, compressible",
        "change_with_position": "Enlarge with dependency, deflate with elevation",
        "valsalva_effect": "Enlarge with Valsalva maneuver"
      },
      "symptoms": [
        {
          "symptom": "Pain",
          "mechanism": "Thrombosis, distension, nerve compression",
          "pattern": "May be episodic with thrombosis episodes"
        },
        {
          "symptom": "Swelling",
          "pattern": "Worse with dependency, activity"
        },
        {
          "symptom": "Functional impairment",
          "location_dependent": "Joint involvement, muscle involvement"
        }
      ],
      "complications": [
        "Localized intravascular coagulopathy (LIC) - elevated D-dimer, low fibrinogen",
        "Bleeding (spontaneous or post-procedural)",
        "Thrombophlebitis episodes",
        "Joint arthropathy (intraarticular VM)",
        "Cosmetic disfigurement"
      ],
      "triggers_for_expansion": [
        "Puberty (hormonal)",
        "Pregnancy",
        "Trauma",
        "Infection",
        "Incomplete treatment"
      ]
    },
    "diagnosis": {
      "clinical_features": [
        "Blue, compressible mass",
        "Enlarge with dependency/Valsalva",
        "Present since birth (may not be noticed initially)",
        "Palpable phleboliths"
      ],
      "imaging": [
        {
          "modality": "MRI",
          "gold_standard": true,
          "findings": [
            "High signal on T2-weighted images",
            "No flow voids (low-flow)",
            "Phleboliths (low signal foci)",
            "Enhancement with contrast (slow, heterogeneous)"
          ],
          "sequences": "T1, T2 fat-sat, contrast-enhanced"
        },
        {
          "modality": "Ultrasound",
          "utility": "Initial assessment, guide intervention",
          "findings": "Compressible, low-flow or no-flow on Doppler, phleboliths with shadowing"
        },
        {
          "modality": "Plain radiograph",
          "findings": "Phleboliths (calcified, laminated appearance)",
          "utility": "Supportive finding"
        },
        {
          "modality": "Direct puncture venography",
          "utility": "Performed during sclerotherapy to assess extent and drainage"
        }
      ],
      "laboratory": {
        "d_dimer": "Often elevated (LIC)",
        "fibrinogen": "May be low in extensive lesions",
        "coagulation_panel": "Before procedures, especially extensive lesions"
      }
    },
    "management": {
      "conservative": {
        "compression": {
          "indication": "All patients with extremity VM",
          "benefit": "Reduces swelling, pain, may slow progression",
          "type": "Custom compression garments"
        },
        "analgesia": "NSAIDs for pain, especially during thrombosis episodes",
        "anticoagulation": {
          "indication": "LIC with low fibrinogen, perioperative prophylaxis",
          "agents": "LMWH typically"
        }
      },
      "sclerotherapy": {
        "first_line": true,
        "agents": [
          {
            "agent": "Sodium tetradecyl sulfate (STS)",
            "concentration": "1-3%",
            "technique": "Foam or liquid"
          },
          {
            "agent": "Polidocanol",
            "concentration": "1-3%",
            "technique": "Foam preferred"
          },
          {
            "agent": "Absolute ethanol",
            "potency": "Most potent",
            "risks": "Higher complication rate (nerve injury, skin necrosis)"
          },
          {
            "agent": "Bleomycin",
            "advantage": "Less swelling post-procedure"
          }
        ],
        "technique": [
          "Ultrasound or fluoroscopic guidance",
          "Direct puncture of VM",
          "Venography to assess drainage",
          "Sclerosant injection",
          "Multiple sessions typically required"
        ],
        "outcomes": {
          "symptom_improvement": "70-90%",
          "volume_reduction": "Variable, rarely complete involution",
          "recurrence": "Common, may need maintenance treatment"
        }
      },
      "surgical": {
        "indications": [
          "Well-localized, resectable lesions",
          "Failed sclerotherapy",
          "Functional impairment",
          "Cosmetic concerns (selected cases)"
        ],
        "principles": [
          "Complete excision if possible",
          "Preoperative sclerotherapy reduces bleeding",
          "Consider staged approach for large lesions",
          "High recurrence risk with incomplete excision"
        ]
      },
      "medical_therapy": {
        "sirolimus": {
          "mechanism": "mTOR inhibitor affecting PI3K/AKT/mTOR pathway",
          "evidence": "Case series showing benefit in extensive, refractory VM",
          "status": "Off-label, consider for severe cases"
        }
      }
    },
    "prognosis": {
      "natural_history": "Slow progression throughout life, may accelerate with hormonal changes",
      "treatment_outcomes": "Symptomatic improvement achievable in most; cure rare for extensive lesions",
      "quality_of_life": "Significantly impacted in extensive disease"
    },
    "statement": "Venous Malformations is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Vascular-Malformations that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Venous Malformations helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Venous Malformations include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Venous Malformations."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "relationships": {
    "requires": [
      "vascular:diagnostics:mri-vascular",
      "vascular:anatomy:venous-system"
    ],
    "enables": [
      "vascular:procedures:sclerotherapy"
    ],
    "related_to": [
      "vascular:vm:avm-peripheral",
      "vascular:vm:lymphatic-malformations"
    ],
    "skos:broader": [
      "http://dbpedia.org/resource/Knowledge"
    ],
    "skos:related": [
      "http://dbpedia.org/resource/Concept"
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Venous_Malformations"
    ]
  },
  "educational": {
    "learning_objectives": [
      "Classify venous malformations using ISSVA terminology",
      "Recognize clinical features distinguishing VM from other vascular anomalies",
      "Select appropriate imaging modalities for diagnosis",
      "Understand the role of sclerotherapy as first-line treatment",
      "Manage localized intravascular coagulopathy"
    ],
    "key_points": [
      "Venous malformations are low-flow lesions present from birth",
      "MRI is gold standard - high T2 signal, no flow voids, phleboliths",
      "Sclerotherapy is first-line treatment for most symptomatic VMs",
      "Check D-dimer/fibrinogen before procedures in extensive lesions",
      "Complete cure is rare - treatment is for symptom control"
    ],
    "clinical_pearls": [
      "Blue, compressible mass that enlarges with Valsalva = VM until proven otherwise",
      "Phleboliths on X-ray are pathognomonic",
      "Elevated D-dimer is expected - don't reflexively anticoagulate",
      "Multiple treatment sessions are the rule, not the exception"
    ]
  },
  "references": {
    "evidence_basis": "ISSVA classification, consensus guidelines, case series",
    "key_guidelines": [
      {
        "organization": "ISSVA",
        "topic": "Classification of vascular anomalies",
        "year": 2018
      }
    ],
    "terminology": {
      "snomed_ct": "400047006",
      "icd10": "Q27.4"
    }
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). Venous Malformations. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "owl:sameAs": "http://dbpedia.org/resource/Venous_Malformations",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}